63 Biggest Movers From Yesterday

Gainers

• Audentes Therapeutics Inc BOLD shares climbed 106% to close at $58.93 on Tuesday after the company agreed to be acquired by Astellas Pharma for $60 per share in cash.
• DarioHealth Corp. DRIO rose 49.1% to close at $7.47 after the company reported the launch of Dario-powered digital diabetes program on Walmart.com.
• Corvus Pharmaceuticals, Inc. CRVS climbed 41% to close at $4.47.
• Akerna Corp. KERN gained 38% to close at $12.50.
• Atreca, Inc. BCEL gained 32.3% to close at $13.34 after the company reported the FDA clearance of investigational new drug application for ATRC-101.
• ViewRay, Inc. VRAY shares rose 30.6% to close at $4.44 after the company announced it has signed a memorandum of understanding for collaboration with Elekta AB and Medtronic. The company also announced a $75 million common stock offering.
• Calyxt, Inc. CLXT shares rose 28.8% to close at $4.70.
• Lands' End, Inc. LE shares gained 21% to close at $14.24 after reporting upbeat Q3 earnings.
• Equillium, Inc. EQ gained 20.5% to close at $3.99.
• Iterum Therapeutics plc ITRM rose 20.2% to close at $3.15.
• Wrap Technologies, Inc. WRTC shares surged 17.2% to close at $5.05.
• uniQure N.V. QURE rose 16.7% to close at $63.92 after analysts from Goldman Sachs and Cowen & Co initiated coverage on the company's stock with bullish ratings.
• Super League Gaming, Inc. SLGG gained 15.8% to close at $2.71.
• Mesa Air Group, Inc. MESA climbed 15.6% to close at $8.09.
• Axsome Therapeutics, Inc. AXSM shares rose 15.1% to close at $45.61 after the company disclosed that AXS-12 achieved primary endpoint in concert Phase 2 trial in narcolepsy.
• Rubius Therapeutics, Inc. RUBY gained 14.4% to close at $8.27.
• Akebia Therapeutics, Inc. AKBA surged 14.1% to close at $6.07.
• Chimerix, Inc. CMRX gained 13.8% to close at $2.72.
• Stage Stores, Inc. SSI shares climbed 13.8% to close at $5.45.
• Synlogic, Inc. SYBX rose 13.5% to close at $2.35.
• Yunji Inc. YJ climbed 13% to close at $4.70.
• Apellis Pharmaceuticals, Inc. APLS gained 11.4% to close at $29.93.
• Ardelyx, Inc. ARDX jumped 11.2% to close at $8.05 after the company announced positive topline results from its Phase 3 of PHREEDOM. Jefferies also maintained its Buy rating and raised its price target from $6 to $11 per share.
• Zovio Inc ZVO gained 11% to close at $2.23.
• Harmony Gold Mining Company Limited HMY rose 10.8% to close at $3.28 amid US-China trade uncertainty after Trump implied a deal many not be reached until 2020. Continuing trade war concerns have led investors into 'safe-haven' assets such as gold and silver.
• Xenon Pharmaceuticals Inc. XENE gained 10.3% to close at $13.58.
• Proteostasis Therapeutics, Inc. PTI rose 10% to close at $2.64.
• REGENXBIO Inc. RGNX jumped 9.4% to close at $44.50.
• Sibanye Gold Limited SBGL rose 9.3% to close at $8.83.
• Sorrento Therapeutics, Inc. SRNE shares rose 9.1% to close at $3.73.
• Merrimack Pharmaceuticals, Inc. MACK gained 9% to close at $4.12. Merrimack received $5 million milestone payment from Ipsen, triggered by Ipsen's decision to progress trial evaluating ONIVYDE.
• Arrowhead Pharmaceuticals, Inc. ARWR gained 8.4% to close at $68.66. Arrowhead Pharmaceuticals said it intends to offer 4 million shares of its common stock in an underwritten public offering.
• Sangamo Therapeutics, Inc. SGMO climbed 6.4% to close at $11.37 in sympathy with Audentes Therapeutics after the company announced it will be acquired by Astellas Pharma for $60 per share in cash.
• Amneal Pharmaceuticals Inc AMRX rose 5.2% to close at $4.04 after the company reported the FDA approval and launch of generic carafate.
• AK Steel Holding Corporation AKS rose 4.2% to close at $3.01 after Cleveland-Cliffs announced plans to acquire the company for $3.36 per share.

Check out these big penny stock gainers and losers

Losers

• ASLAN Pharmaceuticals Limited ASLN shares tumbled 49.6% to close at $2.62 on Tuesday after the company priced a 5.2 million ADS offering at $2.50 per ADS.
• Protagonist Therapeutics, Inc. PTGX dropped 47% to close at $4.69 after the company reported preliminary Phase 2 results with hepcidin mimetic PTG-300 in the treatment of transfusion dependent beta-thalassemia.
• Cara Therapeutics, Inc. CARA dropped 34.6% to close at $16.93 after the company reported mixed results from its Phase 2 trial of Oral Korsuva in chronic kidney disease patients with moderate-to-severe pruritus.
• Aldeyra Therapeutics, Inc. ALDX dipped 32.4% to close at $5.06 after the company announced positive top-line results from Part 1 of the adaptive Phase 3 study dubbed RENEW, which evaluated ADX-102 (topical ocular reproxalap) for dry eye syndrome. ADX-102 was found statistically superior to vehicle in Ocular Discomfort &4-Symptom Questionnaire ocular endpoints for dryness, discomfort, burning, grittiness and stinging. For the co-primary endpoint of fluorescein nasal region ocular staining, it did not reach statistical significance.
• Clovis Oncology, Inc. CLVS shares fell 29% to close at $11.67.
• CBL & Associates Properties, Inc. CBL dropped 24.4% to close at $1.02 after announcing the suspension of common and preferred stock dividends. The company says it sees a decline in net operating income as a result of ‘heightened retailer bankruptcies, restructurings and store closings in 2019.’
• CooTek (Cayman) Inc. CTK fell 22.6% to close at $4.55.
• Resonant Inc. RESN dropped 18.1% to close at $1.76.
• Nine Energy Service, Inc. NINE fell 16.2% to close at $4.61.
• Liquid Media Group Ltd. YVR dipped 16% to close at $2.89.
• Duluth Holdings Inc. DLTH dropped 14.8% to close at $7.71. Stifel Nicolaus maintained Duluth Holdings with a Hold and lowered the price target from $11 to $9.
• Just Energy Group Inc. JE fell 14.1% to close at $1.95 on continued momentum after the company announced it would suspend the dividend on its Series A preferred stock.
• Puma Biotechnology, Inc. PBYI fell 12.9% to close at $9.35
• Safe-T Group Ltd SFET dipped 11.9% to close at $5.40.
• Oramed Pharmaceuticals Inc. ORMP dropped 11.7% to close at $5.05.
• Ruhnn Holding Limited RUHN dipped 11.4% to close at $6.29.
• Plug Power Inc. PLUG fell 11.1% to close at $3.38 after the company announced a 40 million share common stock offering.
• Eyenovia, Inc. EYEN fell 10.7% to close at $3.59.
• Cleveland-Cliffs Inc. CLF fell 10.7% to close at $7.51 after the company announced it will acquire AK Steel for approximately $3 billion.
• InMode Ltd. INMD dropped 10.2% to close at $43.99.
• Tufin Software Technologies Ltd. TUFN dropped 9.7% to close at $17.23 after the company announced the launch of secondary public offering of ordinary shares.
• Akari Therapeutics, Plc AKTX shares declined 9.3% to close at $1.96.
• TTEC Holdings Inc TTEC fell 9.3% to close at $40.57 after the company reported a 3 million share offering by selling shareholders.
• Adient plc ADNT fell 8.5% to close at $20.58.
• Avita Medical Limited RCEL shares dropped 7.2% to close at $7.84.
• Venator Materials PLC VNTR dropped 6.7% to close at $3.61.
• RPC, Inc. RES fell 5.9% to close at $3.66.
• DouYu International Holdings Ltd DOYU dropped 4.1% to close at $7.20 after JP Morgan downgraded the company's stock from Overweight to Neutral and lowered the price target from $10 to $8.